中文
English
한국어
日本語
Español
Français
Русский
| カタログ番号 | HX861016 |
|---|---|
| 説明 |
Research Grade Lerdelimumab (HX861016) is a human monoclonal antibody detecting Glioblastoma-derived T-cell suppressor factor in ELISA, Bioactivity: FACS, Functional assay, Research in vivo. Suitable for Human.
Highlights
|
| 種反応性 | Human |
| アプリケーション | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 宿主種 | Human |
| クローン性 | Monoclonal |
| アイソタイプ | IgG4-lambda |
| 発現システム | Mammalian cells |
| 種 | Human |
| ターゲット | Glioblastoma-derived T-cell suppressor factor, TGF-beta-2, LAP, G-TSF, TGFB2, Cetermin, Transforming growth factor beta-2 proprotein |
| エンドトキシンレベル | < 10 EU/mg |
| 純度 | >95% as determined by SDS-PAGE. |
| 精製 | Protein A/G purified from cell culture supernatant. |
| アクセッション番号 | P61812 |
| 形態 | Liquid |
| 保存バッファー | 0.01M PBS pH 7.4 データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。 |
| 安定性と保存 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 別名 | CAT-152, Trabio, 285985-06-0 |
| 背景 | Transforming growth factor beta-2 proprotein (Glioblastoma-derived T-cell suppressor factor,TGF-beta-2,LAP,G-TSF,TGFB2,Cetermin,Transforming growth factor beta-2 proprotein) is a ~47 kDa protein. Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-2 (TGF-beta-2) chains, which constitute the regulatory and active subunit of TGF-beta-2, respectively. |
| 注意事項 | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype Control | Human IgG4 (S228P) Recombinant Isotype Control Antibody (13R4) (HP298207) |
Detects TGFB2 in indirect ELISAs.
SDS-PAGE for Research Grade Lerdelimumab
+86-027-65523339
中国武漢市深敦寺路666号C棟、武漢、430206
